The 2013 Lasker-DeBakey Clinical Medicine Research Award and cochlear implants: France unjustly overlooked…!  by Chouard, C.-H.
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ditorialhe  2013  Lasker-DeBakey  Clinical  Medicine  Research  Award  and  cochlear
mplants:  France  unjustly  overlooked. .  .!Four countries, France, the USA, Austria and Australia – in
hat chronological order – played key roles in the development
f multi-electrode cochlear implants (http://recorlsa.online.fr/
mplantcochleaire/historique.html). In 2010, I sketched out, in
hese pages, the story played out all over the world [1], which had
een my  own for 40 years.
For almost half a century, following Djourno and Eyriès, France
as made a large contribution to the success of these multi-
lectrode cochlear implants, which have lived up to almost all
he hopes of their even most utopian promoters, far beyond the
nitial expectations of those who pioneered them. Total hearing
oss can more or less always be overcome, even when neona-
al, and deaf-mutism is thus now becoming a rarity. Moreover,
ulti-electrode cochlear implants are now being ﬁtted in partial
evere hearing loss, and the reliability of the material over time
s such that bilateral implantation is often indicated nowadays,
mproving overall auditory performance and acoustic spatial per-
eption. Even more remarkable is that cochlear implants have led
n to the advent of auditory brainstem implants, the very ﬁrst
mplanted intracranial encephalic electrostimulators – a prosthesis
hat should not be underestimated, however rare its indica-
ions.
Quite rightly, therefore, the Lasker jury selected this topic for its
linical Medicine Research Award, delivered on September 10th,
013. The choice of actual prize winners, on the other hand, was
urprising, inasmuch as, of the four countries that played a role
n the development of cochlear implants, only France was over-
ooked.
The jury’s decision testiﬁes, in this ﬁeld, to the oblivion into
hich France was cast at the end of the last century.
More than 10 years after retiring, ﬁrst from my  Depart-
ent, then from my  lab, I felt I had to react to this strange
versight. As the former head of a team, originally based in
aris, whose work had, for a quarter of a century, focused on
ulti-electrode cochlear implantation (http://recorlsa.online.fr/
mplantcochleaire/historicfrancais.html) and had rapidly attracted
upport from numerous other university hospital initiatives nation-
ide, it was my  duty to point out just how singular and incoherent
his omission was.
Or, at the very least, to point out the facts.
For the fact is that the multidisciplinary team of the ENT researchaboratory of the Saint-Antoine Hospital, which I led, can claim
riority for its work in this ﬁeld, in two regards.
Following a clinical research program conducted under scrupu-
ous ethical control [2].
879-7296/$ – see front matter © 2014 Elsevier Masson SAS. All rights reserved.
ttp://dx.doi.org/10.1016/j.anorl.2014.01.002• It was the ﬁrst to implant an 8-electrode cochlear device, in an
adult male with total hearing loss, with a functional range dis-
tributed regularly along the entire frequency range of the cochlea.
This operation was  performed on September 22nd, 1976.
• Encouraged by the quality of the results compared to those
obtained with single-electrode implants, on March 16th, 1977
the team applied for the ﬁrst patent for an implantable hearing
aid in humans. The French patent, No. 77/07824, issued in 1977
[3], was taken up by Bertin & Co. following electrophysiological
studies conducted by Patrick MacLeod, Director of Studies at the
École Pratique des Hautes Études, which at that time was part of
the Collège de France in Paris. This ﬁrst patent was followed up in
1985 by two  more, concerning the development of implantation
techniques, and priority was at no time ever challenged.
In the light of this two-fold priority, it is interesting to see:
• that, on the English-language website of the Lasker Foun-
dation Awards, G. Clark’s Acceptance Remarks (http://www.
laskerfoundation.org/awards/2013 c accept clark.htm) include
the claim to have performed the ﬁrst multichannel implantation
in 1978;
• and that Clark et al. applied for their Australian patent on Novem-
ber 3rd, 1977.
In these developments, Patrick MacLeod and I had precedence
over all three prize winners of the 2013 Lasker Clinical Medicine
Research Award.
Our work and clinical results were subsequently regularly pub-
lished in English-language journals. They were cited as early as
1977 [4], and a recent retrospective historical review [5], published
in 2012, clearly identiﬁes our priority in the ﬁeld.
The third prize winner has, since 1988, been promoting
what he calls “Continuous Interleaved Stimulation” (CIS), a sig-
nal processing strategy that involves a slight modiﬁcation of the
one we described. In his experimental human studies, however, he
has never actually demonstrated the beneﬁt in terms of auditory
rehabilitation of this device over the straightforward procedure we
reported 10 years previously.These are facts of which the scientiﬁc community should be
aware of.
It is to be regretted that the Lasker jury did not take account
of this priority or indeed of the French contribution as a whole
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nd did not include the Paris team among the pioneers of the
ulti-electrode cochlear implantation therapy which it sought to
ecognize by its Award.
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